Related Experiment Video
Updated: Jun 28, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
[Research on the anti-tumor effects of CRYAB in prostate cancer]
Chun-Lei Zhang1, You Hu1, Dong-Xing Wang1
1Department of Urology, The 940 Hospital of Joint Logistics Support Force of Chinese PLA, Lanzhou, Gansu 730050, China.
Zhonghua Nan Ke Xue = National Journal of Andrology
|April 15, 2024
Summary
Alpha-crystallin B chain (CRYAB) is downregulated in prostate cancer (PCa), inhibiting tumor cell proliferation and metastasis. CRYAB shows significant diagnostic and prognostic value for PCa progression and survival.
Area of Science:
- Molecular oncology
- Cancer biology
- Biomarker discovery
Context:
- Prostate cancer (PCa) exhibits complex molecular underpinnings influencing patient prognosis.
- Identifying novel biomarkers for PCa diagnosis and treatment is crucial.
Purpose:
- To investigate the role of Alpha-crystallin B chain (CRYAB) in prostate cancer progression.
- To evaluate CRYAB as a potential diagnostic and prognostic biomarker for PCa.
Summary:
- CRYAB expression is significantly downregulated in PCa tissues and cells compared to normal controls.
- Overexpression of CRYAB suppresses PCa cell proliferation, invasion, migration, and promotes apoptosis.
- CRYAB influences epithelial-mesenchymal transition markers (CDH1, CDH2) and correlates with Gleason score.
Impact:
- CRYAB demonstrates potential as a diagnostic marker with an ROC curve area of 0.914.
- CRYAB serves as a prognostic indicator for progression-free and disease-specific survival in PCa patients.
- CRYAB's association with anti-tumor functions highlights its therapeutic potential in prostate cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K